Photodynamic therapy for choroidal neovascularization. The Jules Gonin Lecture, Montreux, Switzerland, 1 September 2002
- PMID: 12719985
- DOI: 10.1007/s00417-003-0623-y
Photodynamic therapy for choroidal neovascularization. The Jules Gonin Lecture, Montreux, Switzerland, 1 September 2002
Similar articles
-
Photodynamic therapy in patients with idiopathic choroidal neovascularization.Jpn J Ophthalmol. 2004 Jul-Aug;48(4):422-4. doi: 10.1007/s10384-004-0079-6. Jpn J Ophthalmol. 2004. PMID: 15295678 No abstract available.
-
Apparent disappearance of choroidal neovascularization after initial photodynamic therapy with verteporfin.Arch Ophthalmol. 2002 Nov;120(11):1588-90. Arch Ophthalmol. 2002. PMID: 12427082 No abstract available.
-
Photodynamic therapy for extrafoveal choroidal neovascularization associated with choroidal nevus.Retina. 2006 Apr;26(4):477-9. doi: 10.1097/01.iae.0000238543.67003.6a. Retina. 2006. PMID: 16603973 No abstract available.
-
The role of photodynamic therapy in ophthalmology.Br J Hosp Med (Lond). 2006 Dec;67(12):647-50. Br J Hosp Med (Lond). 2006. PMID: 17328448 Review. No abstract available.
-
Photosensitizers and Photodynamic Therapy: Verteporfin.Dev Ophthalmol. 2016;55:330-6. doi: 10.1159/000434704. Epub 2015 Oct 26. Dev Ophthalmol. 2016. PMID: 26501167 Review.
Cited by
-
Verteporfin-induced formation of protein cross-linked oligomers and high molecular weight complexes is mediated by light and leads to cell toxicity.Sci Rep. 2017 Apr 21;7:46581. doi: 10.1038/srep46581. Sci Rep. 2017. Retraction in: Sci Rep. 2024 May 14;14(1):11040. doi: 10.1038/s41598-024-61893-8. PMID: 28429726 Free PMC article. Retracted.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources